Diplomat Pharmacy, Inc.

Company: Diplomat Pharmacy, Inc.

Class Period: February 26, 2018 — February 21, 2019

Court: U.S.D.C. – Central District of California

Deadline: TBD

A shareholder class action complaint has been filed against Diplomat Pharmacy, Inc. (“Diplomat”) on behalf of investors who purchased shares of the Company’s stock between February 26, 2018 and February 21, 2019 (the “Class Period”).

The complaint alleges that the defendants made false and misleading statements and/or failed to disclose material adverse information to investors during the Class Period concerning the Company’s success in integrating and growing its pharmacy benefit management (“PBM”) business.  Specifically, the complaint alleges that defendants failed to disclose or indicate that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; and (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior.

According to the complaint, on February 22, 2019, Diplomat announced that it was postponing the release of its Form 10-K for the fiscal year ended December 31, 2018 due to a “recent determination” that it would need to record a non-cash impairment charge upwards of approximately $630 million relating to 2017 acquisitions for its PBM business. Following this news, shares of the Company’s stock fell $7.59 per share, or over 56% in value, to close on February 22, 2019 at $5.87 per share.

A shareholder class action complaint has been filed against Conagra Brands, Inc. (“Conagra”) on behalf of investors who purchased shares of the Company’s stock between June 27, 2018 and December 19, 2018 (the “Class Period”).

The complaint alleges that the defendants made false and misleading statements and/or failed to disclose material adverse information to investors during the Class Period concerning Conagra’s acquisition of Pinnacle Foods, Inc. (“Pinnacle”).

According to the complaint, on December 20, 2018, Conagra “revealed that Pinnacle’s three leading brands had ‘suffered sales and distribution losses’ in 2018, and accounted ‘for the vast majority of Pinnacle’s current challenges’ due to self-inflicted subpar innovation and executional missteps.” Following this news, shares of the Company’s stock fell $4.81 per share, or over 17% in value, to close on December 20, 2018 at $24.28 per share.

Diplomat shareholders who purchased shares of the Company stock prior to February 21, 2019 are encouraged to contact Kaskela Law at (888) 715 – 1740, or by completing the information form on this page, to discuss their legal rights and options with respect to this action.

Submit Your Information

  • This field is for validation purposes and should be left unchanged.